ProEthic Pharmaceuticals, Inc. has named Regan Campbell Ward · McCann (RCW) as its agency of record for two pain-relief products expected to launch in 2008. The products are PRO-513, a treatment for migraine symptoms, and PRO-571 for short-term acute pain. There was no prior agency on either of these products. The assignment will be handled out of RCW's New York office by MaryLynn Kargman and Erik Christman. The primary contacts at ProEthic are Angie Rush and Marcus Elrod.